Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen

AUTOR(ES)

Sutkowski, Natalie

FONTE

American Society for Microbiology

RESUMO

Superantigens are microbial proteins that strongly stimulate T cells. We described previously that the Epstein-Barr virus (EBV) transactivates a superantigen encoded by the human endogenous retrovirus, HERV-K18. We now report that the transactivation is dependent upon the EBV latent cycle proteins. Moreover, LMP-2A is sufficient for induction of HERV-K18 superantigen activity.

Documentos Relacionados

• Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
• A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.
• Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP.
• Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Half-Life in Epithelial Cells Is Down-Regulated by Lytic LMP-1
• Human-Specific Integrations of the HERV-K Endogenous Retrovirus Family